Real-world study finds esketamine combined with an SNRI linked to lower mortality, hospitalization, and relapse rates compared to esketamine plus SSRI in treatment-resistant depression.
A large Ontario cohort study found that 1 in 5 adults treated in hospital for cannabis use were later diagnosed with dementia, with risk significantly higher than in the general population.
The FDA has issued a safety alert on compounded topical finasteride products, citing adverse events and emphasizing the lack of regulatory approval or safety evaluation.
The FDA and HHS announced plans to eliminate petroleum-based synthetic food dyes, citing potential health risks and aligning with global safety standards.
Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.